[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366839-105":59,"doc-detail-366839-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","incidence-and-mortality-trend-of-liver-cancer-in-iran-from-1990-to-2021-epidemiological-investigation","Incidence and mortality trend of liver cancer in Iran from 1990 to 2021 - epidemiological investigation","","Evaluating liver cancer burden in Iran from 1990 to 2021, the study uses Global Burden of Disease data to quantify age-standardized incidence and mortality trends. Incidence increased to 2.70 per 100,000 in 2021 and mortality to 2.87 per 100,000, with positive average annual percent changes. Men showed a higher burden than women, and burden increased with age. NASH-related liver cancer rose markedly, while Ardebil exhibited the strongest provincial increases. Findings support prevention targeting major risk factors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/incidence-and-mortality-trend-of-liver-cancer-in-iran-from-1990-to-2021-epidemiological-investigation/366839/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/incidence-and-mortality-trend-of-liver-cancer-in-iran-from-1990-to-2021-epidemiological-investigation/366839.png","ImageObject",300,407,{"name":92,"@type":93},"RuangKosong","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and indicators are used to assess liver cancer trends in Iran?","Question",{"text":112,"@type":113},"The study extracts data from the Global Burden of Disease study and uses age-standardized incidence and mortality rates as main indicators, alongside average annual percent change calculations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did liver cancer incidence and mortality change by 2021?",{"text":117,"@type":113},"In 2021, incidence increased to 2.70 per 100,000 and mortality increased to 2.87 per 100,000, both showing positive average annual percent changes over the study period.",{"name":119,"@type":110,"acceptedAnswer":120},"Which groups or factors were associated with higher or changing burden?",{"text":121,"@type":113},"Men had a higher burden than women, burden became more prominent with increasing age, and NASH-related liver cancer showed a substantial shift upward compared with other risk factors. Ardebil had the largest provincial increases.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366839,1790335908,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cohort Study  \nIncidence and mortality trend of liver cancer in Iran from 1990 to 2021: an epidemiological investigation using the Global Burden of Disease study  \nOnika Kazi, MDa , Shokoufeh Hamidzadeh, MDb , Amirhossein Ghaseminejad-Raeini, MDc , Alireza Azarboo, MDc , Amirhossein Shirinezhad, MDc ,*  \nBackground: The burden of liver cancer across the world is one of the most concerning. Iran, as a developing country, lacks a comprehensive review of liver cancer burden in recent years. This study aimed to evaluate the changing burden of liver cancer in Iran from 1990 to 2021.  \nMethods: Data were extracted from the Global Burden of Disease study. Age-standardized incidence and mortality rates (ASIR, ASMR) were the main metrics used in this study. Average annual percent change (AAPC) was calculated for Iran and each province.  \nResults: Liver cancer incidence rate in Iran increased to 2.70 [2 .39 to 3 .04] per 100 000 population in 2021 with an AAPC of 0.85 [0 .61 to 1.08] . Mortality of liver cancer in 2021 increased to 2.87 [2 .55 to 3 .23], representing an AAPC of 0.83 [0 .32 to 1.35] . Men faced a higher burden than women. The burden of liver cancer became more prominent with increasing age. The Incidence of NASH-related liver cancer shifted remarkably during the studied time period, surpassing trends of other risk factors (AAPC: 1.89 [1 .75 to 2 .03]) . Ardebil showed the most significant increasing trends in incidence and mortality rates compared to other provinces. Incidence of liver cancer remained low in lower SDI provinces but gradually increased when moving towards high SDI ones, suggesting a positive correlation.  \nConclusion: This study highlights the concern for liver cancer rate and related death in Iran due to increasing shifts in mortality rates and deaths. Iranian policymakers must implement feasible preventive approaches to control liver cancer's major risk factors, such as NASH and Alcohol use.  \nKeywords: incidence, Iran, liver cancer, mortality, trend  \nIntroduction  \nLiver cancer is among the three cancers with the highest mortality rate and has the second-highest death rate among the most prevalent cancers[1–4] . Based on estimations of GLOBACAN, in 2020, nearly one million individuals were diagnosed with liver cancer and 830 200 died of it[1,3] . While liver cancer incidence trends vary across regions, global cases have been rising [2] .  \naSchool of Medicine, Shahid Beheshti Medical University (SBMU), Tehran, Iran, bDepartment of Internal Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran and cSchool of Medicine, Tehran  \nUniversity of Medical Sciences, Tehran, Iran  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding author. Address: School of Medicine, Tehran University ofMedical Sciences, Tehran 1416634793, Iran. Tel.: +98 910 208 8232.  \n[E-mail: Amirhosseinsh.yashar@gmail.com](E-mail: Amirhosseinsh.yashar@gmail.com) (A. Shirinezhad).  \nCopyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nAnnals of Medicine & Surgery (2025) 87:8013–8025  \nReceived 9 June 2025; Accepted 20 September 2025  \nPublished online 8 October 2025  \n[http://dx.doi.org/10.1097/MS9.0000000000004040](http://dx.doi.org/10.1097/MS9.0000000000004040)  \nChronic infection with hepatitis B or C virus is a risk factor for liver cancer, along with high alcohol consumption, and conditions like non-alcoholic steatohepatitis (NASH)[5] . In recent decades, dramatic changes in lifestyle and diet have contributed to a staggering rise in NASH prevalence[6] . Between 2010 and 2","cbCaifn3Hej3Yg8k","https://ap.wps.com/l/cbCaifn3Hej3Yg8k","pdf",3716522,13,"English","# Background\n# Methods\n## Data source\n## Metrics and trend analysis\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What data and indicators are used to assess liver cancer trends in Iran?\",\"answer\":\"The study extracts data from the Global Burden of Disease study and uses age-standardized incidence and mortality rates as main indicators, alongside average annual percent change calculations.\"},{\"question\":\"How did liver cancer incidence and mortality change by 2021?\",\"answer\":\"In 2021, incidence increased to 2.70 per 100,000 and mortality increased to 2.87 per 100,000, both showing positive average annual percent changes over the study period.\"},{\"question\":\"Which groups or factors were associated with higher or changing burden?\",\"answer\":\"Men had a higher burden than women, burden became more prominent with increasing age, and NASH-related liver cancer showed a substantial shift upward compared with other risk factors. Ardebil had the largest provincial increases.\"}]","Incidence and mortality trend of liver cancer in Iran from 1990 to 2021 - epidemiological investigation | PDF",1790167868,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e04ff0e5614f0f8d2f47f8287cc5b0d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01fbe8767f897974105d02b57a93ca9c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bff5fa9b30266ba9fee55cce7792e567.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/942cc901b9ddf9f8f7f50e3039ff66e3.webp",980,1306]